Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
AAPS PharmSciTech ; 23(5): 115, 2022 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-35441267

RESUMEN

There is growing concern in the rise of colorectal cancer (CRC) cases globally, and with this rise is the presentation of drug resistance. Like other cancers, current treatment options are either invasive or manifest severe side effects. Thus, there is a move towards implementing safer treatment options. Curcumin (CUR), extracted from Curcuma longa, has received significant attention by scientists as possible alternative to chemotherapeutic agents. It is safe and effective against CRC and nontoxic in moderate concentrations. Crucially, it specifically modulates apoptotic effects on CRC. However, the use of CUR is limited by its low solubility and poor bioavailability in aqueous media. These limitations are surmountable through novel approaches, such as nanoencapsulation of CUR, which masks the physicochemical properties of CUR, thus potentiating its anti-CRC effects. Furthermore, chemical derivatization of CUR is another approach that can be used to address the above constraints. This review spans published work in the last two decades, with key findings employing either of the two approaches, in addition to a combined approach in managing CRC. The combined approach affords the possibility of better treatment outcomes but not widely investigated nor yet clinically implemented.


Asunto(s)
Antineoplásicos , Neoplasias Colorrectales , Curcumina , Antineoplásicos/química , Antineoplásicos/farmacología , Disponibilidad Biológica , Neoplasias Colorrectales/tratamiento farmacológico , Curcumina/química , Curcumina/farmacología , Humanos , Solubilidad
2.
Biomed Pharmacother ; 146: 112553, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34923342

RESUMEN

Vitamin C also known as L-ascorbic acid is a nutrient naturally occurring in many fruits and vegetables and widely known for its potent antioxidant activity. Several studies have highlighted the importance of using high dose vitamin C as an adjuvant anti-cancer therapy. Interestingly, it has been shown that vitamin C is able to modulate the anti-cancer immune response and to help to overcome the resistance to immune checkpoints blockade (ICB) drugs such as cytotoxic T-lymphocyte antigen 4 (CLTA-4) and programmed cell death ligand 1 (PD-L1/PD-1) inhibitors. Indeed, it was reported that vitamin C regulates several mechanisms developed by cancer cells to escape T cells immune response and resist ICB. Understanding the role of vitamin C in the anti-tumor immune response will pave the way to the development of novel combination therapies that would enhance the response of cancer patients to ICB immunotherapy. In this review, we discuss the effect of vitamin C on the immune system and its potential role in empowering cancer immunotherapy through its pro-oxidant potential, its ability to modulate epigenetic factors and its capacity to regulate the expression of different cytokines involved in the immune response.


Asunto(s)
Antineoplásicos/farmacología , Ácido Ascórbico/farmacología , Neoplasias/tratamiento farmacológico , Animales , Antineoplásicos/uso terapéutico , Antineoplásicos Inmunológicos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Ácido Ascórbico/uso terapéutico , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Citocinas/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Resistencia a Antineoplásicos/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Humanos , Inhibidores de Puntos de Control Inmunológico/farmacología , Inhibidores de Puntos de Control Inmunológico/uso terapéutico , Neoplasias/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Microambiente Tumoral/efectos de los fármacos
3.
Biomed Pharmacother ; 107: 534-546, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30114637

RESUMEN

Grape seed powder (GSP) contains high amount of bioactive polyphenols usually used as nutritional supplement or food preservatives due to their antioxidant and scavenging properties. The purpose of the present work was to evaluate the safety of increasing dosage GSP (w/w) of 0.5%, 5%, 10% and 20% corresponding to 0.4, 4, 8 and 16 g/kg bw respectively, when administered sub-chronically to Wistar rats in a 2 month-repeated dosing oral toxicity trial. Overally GSP had no effect on food intake, decreased body weight gain without affecting brain, liver, heart or kidney relative weight. GSP did not alter haematology except an increase in platelets, slightly decreased plasma transaminases, creatinine, urea and xanthine oxidase activity, without affecting uricemia, glycemia, triglyceridemia and cholesterolemia. GSP did not affect intracellular mediators as calcium, free iron or H2O2, but exerted real anti-oxidative properties in the four selected organs as assessed by lower lipoperoxidation and carbonylation, higher non protein thiols and antioxidant enzyme activities as CAT, GPx and SOD. Besides GSP exerted anti-inflammatory properties as supported by lower plasma IL17 A and CRP and higher IL10 and adiponectin. Histopathologically GSP provoked the dilation of heart and kidney arterioles and increased the size of the hippocampal dentate gyrus reflecting higher neurogenesis as assessed by Ki-67 labeling. Under the experimental conditions of the current study, GSP appeared as highly safe even when administered at very high dosage and could find potential applications in a variety of biotic or abiotic stresses-induced multi-organ dysfunction.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Suplementos Dietéticos , Extracto de Semillas de Uva/farmacología , Animales , Hipocampo/efectos de los fármacos , Hipocampo/patología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Neurogénesis/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Especificidad de Órganos , Polvos , Ratas Wistar , Aumento de Peso/efectos de los fármacos
4.
Appl Physiol Nutr Metab ; 43(8): 782-794, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29514007

RESUMEN

Spleen is the largest lymphoid organ and obesity is related to an elevated risk of immunity dysfunction. The mechanism whereby fat adversely affects the spleen is poorly understood. This study was designed to assess the effectiveness of grape seed and skin extract (GSSE) and orlistat (Xenical, Xe) on high-fat diet (HFD)-induced spleen lipotoxicity. Obese rats were treated either with GSSE (4 g/kg body weight) or Xe (2 mg/kg body weight) or GSSE+Xe and monitored for weight loss for 3 months. Animals were then sacrificed and their spleen used for the evaluation of lipotoxicity-induced oxidative stress and inflammation as well as the putative protection afforded by GSSE and Xe treatment. HFD induced body weight gain and glycogen accumulation into the spleen; ectopic deposition of cholesterol and triglycerides and an oxidative stress characterized by increased lipoperoxidation and carbonylation; inhibition of antioxidant enzyme activities, such as catalase, glutathione peroxidase, and superoxide dismutase; depletion of zinc and copper; and a concomitant increase in calcium. HFD also increased plasma pro-inflammatory cytokines, such as interleukin (IL)-6, IL-17A, tumour necrosis factor alpha, and C-reactive protein, and decreased plasma IL-10 and adiponectin. Importantly, GSSE counteracted all the deleterious effects of HFD on spleen (i.e., lipotoxicity, oxidative stress, and inflammation) and the best protection was obtained when combining Xe+GSSE. Combining GSSE with Xe prevented against fat-induced spleen lipotoxicity, oxidative stress, and inflammation; this combination may be beneficial in other diseases related to the spleen.


Asunto(s)
Antiinflamatorios/farmacología , Fármacos Antiobesidad/farmacología , Antioxidantes/farmacología , Dieta Alta en Grasa , Extracto de Semillas de Uva/farmacología , Lactonas/farmacología , Bazo/efectos de los fármacos , Enfermedades del Bazo/prevención & control , Animales , Biomarcadores/metabolismo , Colesterol/metabolismo , Citocinas/sangre , Modelos Animales de Enfermedad , Quimioterapia Combinada , Enzimas/metabolismo , Mediadores de Inflamación/sangre , Peroxidación de Lípido/efectos de los fármacos , Masculino , Orlistat , Estrés Oxidativo/efectos de los fármacos , Carbonilación Proteica/efectos de los fármacos , Ratas Wistar/metabolismo , Bazo/metabolismo , Bazo/patología , Enfermedades del Bazo/metabolismo , Enfermedades del Bazo/patología , Triglicéridos/metabolismo
5.
Biomed Pharmacother ; 87: 519-526, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28076832

RESUMEN

It is unknown whether gender has an impact on brain injury in obesity, and, if so, whether treatment with grape seed and skin flour could exert a protective effect. Both male and female rats were fed a standard diet (SD) or a high fat diet (HFD) during eight weeks and treated with high dosage grape seed and skin flour (GSSF). Fat-induced oxidative stress was evaluated into the brain with a special emphasis on transition metals determination. HFD induced male-cholesterol overload (+78.12%) and an oxidative stress status characterized by increased lipoperoxidation (+68.97%), carbonylation (+40.28%), decreased antioxidant enzyme activities as glutathione peroxidase (-61.07%) and manganese-superoxide dismutase (-35.47%) but not catalase. Additionally HFD depleted the brain from manganese (-71.31%) and dropped glutamine synthetase activity (-36.16%), without affecting copper nor iron nor their associated enzymes. HFD also altered intracellular mediators as superoxide anion (+36.12%), calcium (+44.41%) and also calpain (+76.54%) a calcium dependent protease. Importantly all these alterations were detected exclusively in male brain and were efficiently corrected upon GSSF treatment. In conclusion, GSSF has the potential to alleviate the deleterious lipotoxic effect of HFD treatment that occurred in male brain and perhaps in post-menauposal female brain.


Asunto(s)
Encefalopatías/tratamiento farmacológico , Dieta Alta en Grasa/efectos adversos , Extracto de Semillas de Uva/farmacología , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Semillas/química , Vitis/química , Animales , Antioxidantes/metabolismo , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encefalopatías/metabolismo , Catalasa/metabolismo , Colesterol/metabolismo , Cobre/metabolismo , Suplementos Dietéticos , Femenino , Glutatión Peroxidasa/metabolismo , Masculino , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
6.
Biomed Pharmacother ; 83: 584-592, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27459114

RESUMEN

The present work deal with the effect of alloxan-induced diabetes on kidney oxidative stress and dysfunction of virgin and pregnant rat as well as the protection that may be afforded by high dosage GSSE (4g/kg) treatment. Diabetes affected negatively several kidney function parameters as creatinemia, uremia, uricemia and proteinuria without affecting kidney index. Diabetes also induced an oxidative stress characterized by increased lipid and protein oxidation, a drop in antioxidant enzyme defenses as catalase, superoxide-dismutase, glutathione-peroxidase, an alteration in transition metals as free iron, copper, selenium and associated enzymes and an increase in calpain and acetyl-cholinesterase activities. Tremendously, GSSE treatment protected efficiently against all the deleterious effects of diabetes-induced kidney dysfunction in both virgin and pregnant animals. High dosage GSSE is a safe and potent anti-oxidant that may be further tested in clinical trials for the long-term preservation of kidney function especially in multiple pregnancies.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Sustancias Protectoras/uso terapéutico , Semillas/química , Vitis/química , Animales , Antioxidantes/metabolismo , Biomarcadores/metabolismo , Peso Corporal/efectos de los fármacos , Cromatografía Liquida , Diabetes Mellitus Experimental/patología , Femenino , Espacio Intracelular/metabolismo , Riñón/efectos de los fármacos , Riñón/patología , Riñón/fisiopatología , Peroxidación de Lípido/efectos de los fármacos , Metales/metabolismo , Fenoles/análisis , Extractos Vegetales/farmacología , Embarazo , Sustancias Protectoras/farmacología , Carbonilación Proteica/efectos de los fármacos , Espectrometría de Masas en Tándem
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA